The Nootropic Drug Vinpocetine Inhibits Veratridine-Induced [Ca2+]i Increase in Rat Hippocampal CA1 Pyramidal Cells View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-09

AUTHORS

Tibor Zelles, Laura Franklin, István Koncz, Balázs Lendvai, Gabriella Zsilla

ABSTRACT

The alkaloid derivative vinpocetine (14-ethoxycarbonyl-(3α,16α-ethyl)-14,15-eburnamine; Cavinton) has a well known beneficial effect on brain function in hypoxic and ischemic conditions. While it increases CNS blood flow and improves cellular metabolism, relatively little is known about vinpocetine's underlying molecular mechanisms on the single cell level. Since apoptotic and necrotic cell damage is always preceded by an increase in [Ca2+]i, this study investigated the effect of vinpocetine on [Ca2+]i increases in acute brain slices. Sodium influx is an early event in the biochemical cascade that takes place during ischemia. The alkaloid veratridine can activate this Na+ influx, causing depolarization and increasing [Ca2+]i in the cells. Therefore, it can be used to simulate an ischemic attack in brain cells. Using a cooled CCD camera-based ratio imaging system and cell loading with fura 2/AM, the effect of vinpocetine on [Ca2+]i changes in single pyramidal neurons in the vulnerable CA1 region of rat hippocampal slices was investigated. Preperfusion and continuous administration of vinpocetine (10 μM) significantly inhibited the elevation in [Ca2+]i induced by veratridine (10 μM). When the drug was administered after veratridine, it could accelerate the recovery of cellular calcium levels. Piracetam, another nootropic used in clinical practice, could attenuate the elevation of [Ca2+]i only at a high, 1 mM, concentration. We have concluded that vinpocetine, at a pharmacologically relevant concentration, can decrease pathologically high [Ca2+]i levels in individual rat hippocampal CA1 pyramidal neurons; this effect might contribute to the neuroprotective property of the drug. More... »

PAGES

1095-1100

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1012365408215

DOI

http://dx.doi.org/10.1023/a:1012365408215

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023143015

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11699936


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hippocampus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Vitro Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nootropic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Wistar", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Veratridine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vinca Alkaloids", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.419012.f", 
          "name": [
            "Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zelles", 
        "givenName": "Tibor", 
        "id": "sg:person.01060125111.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060125111.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.419012.f", 
          "name": [
            "Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Franklin", 
        "givenName": "Laura", 
        "id": "sg:person.01310177172.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310177172.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.419012.f", 
          "name": [
            "Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koncz", 
        "givenName": "Istv\u00e1n", 
        "id": "sg:person.0635020074.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635020074.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.419012.f", 
          "name": [
            "Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lendvai", 
        "givenName": "Bal\u00e1zs", 
        "id": "sg:person.01174353511.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174353511.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.419012.f", 
          "name": [
            "Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zsilla", 
        "givenName": "Gabriella", 
        "id": "sg:person.071035575.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.071035575.28"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/a:1021164418478", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051842587", 
          "https://doi.org/10.1023/a:1021164418478"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03160362", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079637563", 
          "https://doi.org/10.1007/bf03160362"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-09", 
    "datePublishedReg": "2001-09-01", 
    "description": "The alkaloid derivative vinpocetine (14-ethoxycarbonyl-(3\u03b1,16\u03b1-ethyl)-14,15-eburnamine; Cavinton) has a well known beneficial effect on brain function in hypoxic and ischemic conditions. While it increases CNS blood flow and improves cellular metabolism, relatively little is known about vinpocetine's underlying molecular mechanisms on the single cell level. Since apoptotic and necrotic cell damage is always preceded by an increase in [Ca2+]i, this study investigated the effect of vinpocetine on [Ca2+]i increases in acute brain slices. Sodium influx is an early event in the biochemical cascade that takes place during ischemia. The alkaloid veratridine can activate this Na+ influx, causing depolarization and increasing [Ca2+]i in the cells. Therefore, it can be used to simulate an ischemic attack in brain cells. Using a cooled CCD camera-based ratio imaging system and cell loading with fura 2/AM, the effect of vinpocetine on [Ca2+]i changes in single pyramidal neurons in the vulnerable CA1 region of rat hippocampal slices was investigated. Preperfusion and continuous administration of vinpocetine (10 \u03bcM) significantly inhibited the elevation in [Ca2+]i induced by veratridine (10 \u03bcM). When the drug was administered after veratridine, it could accelerate the recovery of cellular calcium levels. Piracetam, another nootropic used in clinical practice, could attenuate the elevation of [Ca2+]i only at a high, 1 mM, concentration. We have concluded that vinpocetine, at a pharmacologically relevant concentration, can decrease pathologically high [Ca2+]i levels in individual rat hippocampal CA1 pyramidal neurons; this effect might contribute to the neuroprotective property of the drug.", 
    "genre": "article", 
    "id": "sg:pub.10.1023/a:1012365408215", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085962", 
        "issn": [
          "0364-3190", 
          "1573-6903"
        ], 
        "name": "Neurochemical Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8-9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "26"
      }
    ], 
    "keywords": [
      "effect of vinpocetine", 
      "pyramidal neurons", 
      "rat hippocampal CA1 pyramidal neurons", 
      "rat hippocampal CA1 pyramidal cells", 
      "hippocampal CA1 pyramidal neurons", 
      "hippocampal CA1 pyramidal cells", 
      "fura-2/AM", 
      "CNS blood flow", 
      "CA1 pyramidal neurons", 
      "vulnerable CA1 region", 
      "CA1 pyramidal cells", 
      "rat hippocampal slices", 
      "acute brain slices", 
      "single pyramidal neurons", 
      "cellular calcium levels", 
      "ischemic attack", 
      "necrotic cell damage", 
      "continuous administration", 
      "neuroprotective properties", 
      "hippocampal slices", 
      "CA1 region", 
      "pyramidal cells", 
      "alkaloid veratridine", 
      "brain slices", 
      "ischemic conditions", 
      "blood flow", 
      "calcium levels", 
      "brain cells", 
      "clinical practice", 
      "veratridine", 
      "brain function", 
      "beneficial effects", 
      "sodium influx", 
      "vinpocetine", 
      "cell damage", 
      "biochemical cascade", 
      "early events", 
      "neurons", 
      "relevant concentrations", 
      "drugs", 
      "molecular mechanisms", 
      "cell level", 
      "single-cell level", 
      "cells", 
      "cellular metabolism", 
      "elevation", 
      "influx", 
      "ischemia", 
      "slices", 
      "preperfusion", 
      "levels", 
      "administration", 
      "nootropics", 
      "piracetam", 
      "hypoxic", 
      "effect", 
      "increase", 
      "depolarization", 
      "metabolism", 
      "concentration", 
      "damage", 
      "recovery", 
      "cascade", 
      "study", 
      "AM", 
      "events", 
      "changes", 
      "mechanism", 
      "practice", 
      "function", 
      "cell loading", 
      "imaging system", 
      "attacks", 
      "region", 
      "conditions", 
      "flow", 
      "place", 
      "system", 
      "loading", 
      "properties"
    ], 
    "name": "The Nootropic Drug Vinpocetine Inhibits Veratridine-Induced [Ca2+]i Increase in Rat Hippocampal CA1 Pyramidal Cells", 
    "pagination": "1095-1100", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023143015"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1012365408215"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11699936"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1012365408215", 
      "https://app.dimensions.ai/details/publication/pub.1023143015"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_323.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1023/a:1012365408215"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1012365408215'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1012365408215'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1012365408215'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1012365408215'


 

This table displays all metadata directly associated to this object as RDF triples.

213 TRIPLES      21 PREDICATES      117 URIs      107 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1012365408215 schema:about N06a9380d71e8440781b69cfefe55621c
2 N862abc50fb234e89aca5c98b274b9924
3 N8b277a0d576841a5928ca8e4879c1089
4 N9d2af858e476478fab318d8ee32a2eeb
5 Nb1f90c7bbf04467fae7c93c59cfa39e8
6 Nb5c0f8f5952145a2a1cb8199821b2d88
7 Nc683715883594c40b4382cb0e5c45dab
8 Ne86e6555cf3a491780407683652260bd
9 Nef9385a4a59747389058675ce3f67d13
10 anzsrc-for:11
11 anzsrc-for:1109
12 schema:author N48343d23aa4f4566a9b9a357889102fe
13 schema:citation sg:pub.10.1007/bf03160362
14 sg:pub.10.1023/a:1021164418478
15 schema:datePublished 2001-09
16 schema:datePublishedReg 2001-09-01
17 schema:description The alkaloid derivative vinpocetine (14-ethoxycarbonyl-(3α,16α-ethyl)-14,15-eburnamine; Cavinton) has a well known beneficial effect on brain function in hypoxic and ischemic conditions. While it increases CNS blood flow and improves cellular metabolism, relatively little is known about vinpocetine's underlying molecular mechanisms on the single cell level. Since apoptotic and necrotic cell damage is always preceded by an increase in [Ca2+]i, this study investigated the effect of vinpocetine on [Ca2+]i increases in acute brain slices. Sodium influx is an early event in the biochemical cascade that takes place during ischemia. The alkaloid veratridine can activate this Na+ influx, causing depolarization and increasing [Ca2+]i in the cells. Therefore, it can be used to simulate an ischemic attack in brain cells. Using a cooled CCD camera-based ratio imaging system and cell loading with fura 2/AM, the effect of vinpocetine on [Ca2+]i changes in single pyramidal neurons in the vulnerable CA1 region of rat hippocampal slices was investigated. Preperfusion and continuous administration of vinpocetine (10 μM) significantly inhibited the elevation in [Ca2+]i induced by veratridine (10 μM). When the drug was administered after veratridine, it could accelerate the recovery of cellular calcium levels. Piracetam, another nootropic used in clinical practice, could attenuate the elevation of [Ca2+]i only at a high, 1 mM, concentration. We have concluded that vinpocetine, at a pharmacologically relevant concentration, can decrease pathologically high [Ca2+]i levels in individual rat hippocampal CA1 pyramidal neurons; this effect might contribute to the neuroprotective property of the drug.
18 schema:genre article
19 schema:isAccessibleForFree false
20 schema:isPartOf N47450312d6744b76beed46202e8d1f55
21 N5ad7f79af57a475089462e8767551af3
22 sg:journal.1085962
23 schema:keywords AM
24 CA1 pyramidal cells
25 CA1 pyramidal neurons
26 CA1 region
27 CNS blood flow
28 acute brain slices
29 administration
30 alkaloid veratridine
31 attacks
32 beneficial effects
33 biochemical cascade
34 blood flow
35 brain cells
36 brain function
37 brain slices
38 calcium levels
39 cascade
40 cell damage
41 cell level
42 cell loading
43 cells
44 cellular calcium levels
45 cellular metabolism
46 changes
47 clinical practice
48 concentration
49 conditions
50 continuous administration
51 damage
52 depolarization
53 drugs
54 early events
55 effect
56 effect of vinpocetine
57 elevation
58 events
59 flow
60 function
61 fura-2/AM
62 hippocampal CA1 pyramidal cells
63 hippocampal CA1 pyramidal neurons
64 hippocampal slices
65 hypoxic
66 imaging system
67 increase
68 influx
69 ischemia
70 ischemic attack
71 ischemic conditions
72 levels
73 loading
74 mechanism
75 metabolism
76 molecular mechanisms
77 necrotic cell damage
78 neurons
79 neuroprotective properties
80 nootropics
81 piracetam
82 place
83 practice
84 preperfusion
85 properties
86 pyramidal cells
87 pyramidal neurons
88 rat hippocampal CA1 pyramidal cells
89 rat hippocampal CA1 pyramidal neurons
90 rat hippocampal slices
91 recovery
92 region
93 relevant concentrations
94 single pyramidal neurons
95 single-cell level
96 slices
97 sodium influx
98 study
99 system
100 veratridine
101 vinpocetine
102 vulnerable CA1 region
103 schema:name The Nootropic Drug Vinpocetine Inhibits Veratridine-Induced [Ca2+]i Increase in Rat Hippocampal CA1 Pyramidal Cells
104 schema:pagination 1095-1100
105 schema:productId N3afab0cb0244428e905b783dcd9d7c17
106 N695296f620144883b29523b212be7ade
107 Ndc3023a82bb64b76b60403a6b19a73f4
108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023143015
109 https://doi.org/10.1023/a:1012365408215
110 schema:sdDatePublished 2022-09-02T15:48
111 schema:sdLicense https://scigraph.springernature.com/explorer/license/
112 schema:sdPublisher Ndac160dcf7ae49a69c162afec441e6ed
113 schema:url https://doi.org/10.1023/a:1012365408215
114 sgo:license sg:explorer/license/
115 sgo:sdDataset articles
116 rdf:type schema:ScholarlyArticle
117 N06a9380d71e8440781b69cfefe55621c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Calcium
119 rdf:type schema:DefinedTerm
120 N3afab0cb0244428e905b783dcd9d7c17 schema:name dimensions_id
121 schema:value pub.1023143015
122 rdf:type schema:PropertyValue
123 N47450312d6744b76beed46202e8d1f55 schema:volumeNumber 26
124 rdf:type schema:PublicationVolume
125 N48343d23aa4f4566a9b9a357889102fe rdf:first sg:person.01060125111.31
126 rdf:rest N9a5148922ca3471ba2a613e22c49f010
127 N5ad7f79af57a475089462e8767551af3 schema:issueNumber 8-9
128 rdf:type schema:PublicationIssue
129 N609783cd362747a79bbc29729d76f06e rdf:first sg:person.01174353511.15
130 rdf:rest Ne2a747fab3064cc7b21c44d07ae4a7e8
131 N695296f620144883b29523b212be7ade schema:name pubmed_id
132 schema:value 11699936
133 rdf:type schema:PropertyValue
134 N862abc50fb234e89aca5c98b274b9924 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Veratridine
136 rdf:type schema:DefinedTerm
137 N8b277a0d576841a5928ca8e4879c1089 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Rats, Wistar
139 rdf:type schema:DefinedTerm
140 N9a5148922ca3471ba2a613e22c49f010 rdf:first sg:person.01310177172.07
141 rdf:rest Nc7788d926df24a238e2e48b0e8144ed1
142 N9d2af858e476478fab318d8ee32a2eeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Rats
144 rdf:type schema:DefinedTerm
145 Nb1f90c7bbf04467fae7c93c59cfa39e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Hippocampus
147 rdf:type schema:DefinedTerm
148 Nb5c0f8f5952145a2a1cb8199821b2d88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Animals
150 rdf:type schema:DefinedTerm
151 Nc683715883594c40b4382cb0e5c45dab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Vinca Alkaloids
153 rdf:type schema:DefinedTerm
154 Nc7788d926df24a238e2e48b0e8144ed1 rdf:first sg:person.0635020074.42
155 rdf:rest N609783cd362747a79bbc29729d76f06e
156 Ndac160dcf7ae49a69c162afec441e6ed schema:name Springer Nature - SN SciGraph project
157 rdf:type schema:Organization
158 Ndc3023a82bb64b76b60403a6b19a73f4 schema:name doi
159 schema:value 10.1023/a:1012365408215
160 rdf:type schema:PropertyValue
161 Ne2a747fab3064cc7b21c44d07ae4a7e8 rdf:first sg:person.071035575.28
162 rdf:rest rdf:nil
163 Ne86e6555cf3a491780407683652260bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Nootropic Agents
165 rdf:type schema:DefinedTerm
166 Nef9385a4a59747389058675ce3f67d13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name In Vitro Techniques
168 rdf:type schema:DefinedTerm
169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
170 schema:name Medical and Health Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
173 schema:name Neurosciences
174 rdf:type schema:DefinedTerm
175 sg:journal.1085962 schema:issn 0364-3190
176 1573-6903
177 schema:name Neurochemical Research
178 schema:publisher Springer Nature
179 rdf:type schema:Periodical
180 sg:person.01060125111.31 schema:affiliation grid-institutes:grid.419012.f
181 schema:familyName Zelles
182 schema:givenName Tibor
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060125111.31
184 rdf:type schema:Person
185 sg:person.01174353511.15 schema:affiliation grid-institutes:grid.419012.f
186 schema:familyName Lendvai
187 schema:givenName Balázs
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174353511.15
189 rdf:type schema:Person
190 sg:person.01310177172.07 schema:affiliation grid-institutes:grid.419012.f
191 schema:familyName Franklin
192 schema:givenName Laura
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310177172.07
194 rdf:type schema:Person
195 sg:person.0635020074.42 schema:affiliation grid-institutes:grid.419012.f
196 schema:familyName Koncz
197 schema:givenName István
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635020074.42
199 rdf:type schema:Person
200 sg:person.071035575.28 schema:affiliation grid-institutes:grid.419012.f
201 schema:familyName Zsilla
202 schema:givenName Gabriella
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.071035575.28
204 rdf:type schema:Person
205 sg:pub.10.1007/bf03160362 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079637563
206 https://doi.org/10.1007/bf03160362
207 rdf:type schema:CreativeWork
208 sg:pub.10.1023/a:1021164418478 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051842587
209 https://doi.org/10.1023/a:1021164418478
210 rdf:type schema:CreativeWork
211 grid-institutes:grid.419012.f schema:alternateName Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary
212 schema:name Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary
213 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...